RECURRENT HAIRY CELL LEUKEMIA
Clinical trials for RECURRENT HAIRY CELL LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new RECURRENT HAIRY CELL LEUKEMIA trials appear
Sign up with your email to follow new studies for RECURRENT HAIRY CELL LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill trial targets Tough-to-Treat blood cancer comeback
Disease control Recruiting nowThis study is testing whether a pill called venetoclax can help control hairy cell leukemia that has come back after previous treatments. About 20 adults whose cancer has relapsed will take the daily pill for up to 19 months. Researchers want to see if the treatment shrinks the c…
Matched conditions: RECURRENT HAIRY CELL LEUKEMIA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
New hope for Tough-to-Treat blood cancer
Disease control Recruiting nowThis study is testing a new two-drug combination (tovorafenib + rituximab) for hairy cell leukemia that has come back or hasn't responded to prior treatment. It will also compare this new combo to the current standard treatment (cladribine + rituximab) for patients who haven't st…
Matched conditions: RECURRENT HAIRY CELL LEUKEMIA
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
New drug combo aims to wipe out rare blood cancer
Disease control Recruiting nowThis study is testing a two-step treatment for hairy cell leukemia, a rare blood cancer. First, patients receive a chemotherapy drug (cladribine) to kill cancer cells. Then, they receive an immunotherapy drug (rituximab) to help the immune system clean up any remaining cancer and…
Matched conditions: RECURRENT HAIRY CELL LEUKEMIA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 19, 2026 14:56 UTC